20949-84-2Relevant articles and documents
Synthesis and S(RN)1 reactions in 5-nitrothiazole series
Gellis, Armand,Vanelle, Patrice,Kaafarani, Mustapha,Benakli, Kamel,Crozet, Michel P.
, p. 5471 - 5484 (1997)
A new heterocyclic reductive alkylating agent, the 2-methyl-4-chloromethyl-5-nitrothiazole, has been synthesized and could react with the 2-nitropropane anion as nucleophile, to give the 2-methyl-4-(2-methylpropenyl)-5-nitrothiazole as the major product.
Synthesis of new 1,4-dihydropyridine derivatives containing thiazolyl substituents
Bazargan, Leila,Shafiee, Abbas,Amini, Mohsen,Dezfouli, Ebrahim Bakhshi,Azizi, Ebrahim,Ghaffari, Seyed Mahmood
scheme or table, p. 602 - 609 (2009/10/02)
A series of 4-[2-methyl (or aryl) thiazole-4-yl]-2,6-dimethyl-3,5-diacetyl (or dibenzoyl) 1,4-dihydropyridines were synthesized using a modified Hantzsch reaction involving the condensation of the corresponding aldehyde with acetyl acetone or benzoyl acetone. The preparation of the corresponding aldehydes (2-methylthiazole-4-carboxaldehyde and some 2-arylthiazole-4-carboxaldehydes) was achieved by a simplified protocol of the published synthesis.
Design and synthesis C6-C8 bridged epothilone a
Zhan, Weiqiang,Jiang, Yi,Brodie, Peggy J.,Kingston, David G. I.,Liotta, Dennis C.,Snyder, James P.
supporting information; experimental part, p. 1565 - 1568 (2009/04/10)
A conformationally restrained epothilone A analogue (3) with a short bridge between methyl groups at C6 and C8 was designed and synthesized. Preliminary biological evaluation indicates 3 to be only weakly active (IC50 = 8.5 μM) against the A2780 human ovarian cancer cell line.